Noble Capital Markets Initiates Equity Research Coverage on Nutriband (NTRB)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Nutriband today with his report titled “Initiating Coverage With An Outperform Rating And $13 Price Target”